Gilead designs to post lenacapavir for approval for use as PrEP for the Food and Drug Administration by the end of your year. So this effective new HIV-prevention Device could hit the U.S. marketplace by mid-to-late https://europeantimes.news/2024/08/pope-francis-calls-on-religions-to-unite-to-reduce-demand-for-drugs/